Phimo International Holdings B.V. (PMI) has extended Swedish Match's acceptance period for its offer to shareholders until October 21, 2022, as the offer is awaiting approval from the European Union.
Photo credit: SergeVo
On May 11th, Philip Morris International (PMI) announced a bid of SEK 161.2 billion ($16.14 billion) through its Dutch subsidiary to acquire Swedish Match. The acceptance period for the offer will begin on June 29, 2022, and was initially set to expire on September 30, 2022. PMI stated in a press release that it has obtained all necessary international approvals for the transaction, pending the merger control approval from the European Commission.
According to customary advance notice discussions with the European Commission, the company believes that the Commission will not complete its review of the transaction before the initial acceptance period expires on September 30. The terms and conditions of the offer remain unchanged, aside from an extension of the acceptance period. The board of Swedish Match has recommended that shareholders accept PMI's proposal, but some shareholders have expressed opposition. Reuters reported earlier this year that Bronte Capital, a Swedish Match shareholder, opposed the acquisition, calling the offer price "unacceptable." Another shareholder also questioned whether Swedish Match's long-term value is reflected in PMI's offer.
Meanwhile, according to reports, Elliott Investment Management has been increasing its stake in Swedish Match and plans to oppose PMI's acquisition of Scandinavian Tobacco Group under current terms. However, according to analyst Mads Rosendal of Danske Bank, it is unlikely that Elliott will be able to acquire a significant enough stake in Swedish Match to independently block the deal.
Statement
This article is compiled from third-party information and is intended for industry exchange and learning purposes only.
This article does not represent the viewpoint of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The translation of this article is solely for industry communication and research purposes.
Due to limitations in translation ability, the translated article may not convey the exact same meaning as the original text. Please refer to the original text for accuracy.
2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macao, Taiwan, or foreign-related expressions and positions.
The copyright of compiled information belongs to the original media and authors. If there is any infringement, please contact us to remove it.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
